Phase 1/2 Multicenter Trial of Acalabrutinib in Chinese Patients with Relapsed/refractory Mantle Cell Lymphoma
Leukemia & lymphoma/Leukemia and lymphoma（2024）
关键词
Tyrosine protein kinase inhibitors,leukemia, lymphocytic, chronic, B-cell protein,survival analysis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要